Sfoglia per AUTORE
SOTTILE A
Collezione AOU San Luigi di Orbassano
Items : 5
Increased Lactate Secretion by Cancer Cells Sustains Non-cell-autonomous Adaptive Resistance to MET and EGFR Targeted Therapies. in Cell metabolism / Cell Metab. 2018 Dec 4;28(6):848-865.e6. doi: 10.1016/j.cmet.2018.08.006. Epub 2018 Aug 30.
2018
AOU San Luigi di Orbassano
AOU San Luigi di Orbassano
Apicella M; Giannoni E; Fiore S; Ferrari KJ; Fernández-Pérez D; Isella C; Granchi C; Minutolo F; Sottile A; Comoglio PM; Medico E; Pietrantonio F; Volante M; Pasini D; Chiarugi P; Giordano S; Corso S;
In-parallel comparative evaluation between multiparametric magnetic resonance imaging, prostate cancer antigen 3 and the prostate health index in predicting pathologically confirmed significant prostate cancer in men eligible for active surveillance. in BJU international / BJU Int. 2016 Oct;118(4):527-34. doi: 10.1111/bju.13318. Epub 2015 Oct 12.
2016
AOU San Luigi di Orbassano
AOU San Luigi di Orbassano
Sottile A; Veltri A; Russo F; Manfredi M; De Luca S; Cantiello F; Porpiglia F; Damiano R;
[-2]proPSA versus ultrasensitive PSA fluctuations over time in the first year from radical prostatectomy, in an high-risk prostate cancer population: A first report. in BMC urology / BMC Urol. 2016 Mar 24;16:14. doi: 10.1186/s12894-016-0131-0.
2016
AOU San Luigi di Orbassano
AOU San Luigi di Orbassano
De Luca S; Passera R; Sottile A; Fiori C; Scarpa RM; Porpiglia F;
Prostate health index and prostate cancer gene 3 score but not percent-free Prostate Specific Antigen have a predictive role in differentiating histological prostatitis from PCa and other nonneoplastic lesions (BPH and HG-PIN) at repeat biopsy. in Urologic oncology / Urol Oncol. 2015 Oct;33(10):424.e17-23. doi: 10.1016/j.urolonc.2015.05.032. Epub 2015 Jul 7.
2015
AOU San Luigi di Orbassano
AOU San Luigi di Orbassano
De Luca S; Passera R; Fiori C; Bollito E; Cappia S; Mario Scarpa R; Sottile A; Franco Randone D; Porpiglia F;
Comparison of prostate cancer gene 3 score, prostate health index and percentage free prostate-specific antigen for differentiating histological inflammation from prostate cancer and other non-neoplastic alterations of the prostate at initial biopsy. in Anticancer research / Anticancer Res. 2014 Dec;34(12):7159-65.
2014
AOU San Luigi di Orbassano
AOU San Luigi di Orbassano
De Luca S; Passera R; Bollito E; Manfredi M; Scarpa RM; Sottile A; Randone DF; Porpiglia F;